BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 32728068)

  • 41. Knockdown of LINC01116 inhibits cell migration and invasion in head and neck squamous cell carcinoma through epithelial-mesenchymal transition pathway.
    Wu J; Chen Z; Zhang L; Cao J; Li X; Gong Z; Bo H; Zhang S; He D
    J Cell Biochem; 2020 Jan; 121(1):867-875. PubMed ID: 31452270
    [TBL] [Abstract][Full Text] [Related]  

  • 42. CCL28-induced RARβ expression inhibits oral squamous cell carcinoma bone invasion.
    Park J; Zhang X; Lee SK; Song NY; Son SH; Kim KR; Shim JH; Park KK; Chung WY
    J Clin Invest; 2019 Dec; 129(12):5381-5399. PubMed ID: 31487270
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
    Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
    BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
    Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
    Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteoactivin Promotes Migration of Oral Squamous Cell Carcinomas.
    Arosarena OA; Dela Cadena RA; Denny MF; Bryant E; Barr EW; Thorpe R; Safadi FF
    J Cell Physiol; 2016 Aug; 231(8):1761-70. PubMed ID: 26636434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immunodetection of Epithelial-Mesenchymal Transition and Tumor Proliferation Markers in GLi-1-positive Oral Squamous Cell Carcinoma.
    Dantas RCM; Guimarães VSN; de Souza RO; Valverde LF; Vidal MTA; Nogueira RLR; da Rocha LOS; Araújo GT; Dos Santos JN; Rocha CAG
    Appl Immunohistochem Mol Morphol; 2021 May-Jun 01; 29(5):335-344. PubMed ID: 32769440
    [TBL] [Abstract][Full Text] [Related]  

  • 47. RhoC mediates epidermal growth factor-stimulated migration and invasion in head and neck squamous cell carcinoma.
    Tumur Z; Katebzadeh S; Guerra C; Bhushan L; Alkam T; Henson BS
    Neoplasia; 2015 Jan; 17(1):141-51. PubMed ID: 25622907
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A genetic cell context-dependent role for ZEB1 in lung cancer.
    Zhang T; Guo L; Creighton CJ; Lu Q; Gibbons DL; Yi ES; Deng B; Molina JR; Sun Z; Yang P; Yang Y
    Nat Commun; 2016 Jul; 7():12231. PubMed ID: 27456471
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Porphyromonas gingivalis initiates a mesenchymal-like transition through ZEB1 in gingival epithelial cells.
    Sztukowska MN; Ojo A; Ahmed S; Carenbauer AL; Wang Q; Shumway B; Jenkinson HF; Wang H; Darling DS; Lamont RJ
    Cell Microbiol; 2016 Jun; 18(6):844-58. PubMed ID: 26639759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Carcinogenic epithelial-mesenchymal transition initiated by oral cancer exosomes is inhibited by anti-EGFR antibody cetuximab.
    Fujiwara T; Eguchi T; Sogawa C; Ono K; Murakami J; Ibaragi S; Asaumi JI; Calderwood SK; Okamoto K; Kozaki KI
    Oral Oncol; 2018 Nov; 86():251-257. PubMed ID: 30409309
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of DSPP and MMP20 Silencing on Adhesion, Metastasis, Angiogenesis, and Epithelial-Mesenchymal Transition Proteins in Oral Squamous Cell Carcinoma Cells.
    Aseervatham J; Ogbureke KUE
    Int J Mol Sci; 2020 Jul; 21(13):. PubMed ID: 32630820
    [TBL] [Abstract][Full Text] [Related]  

  • 53. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genome-wide cooperation of EMT transcription factor ZEB1 with YAP and AP-1 in breast cancer.
    Feldker N; Ferrazzi F; Schuhwerk H; Widholz SA; Guenther K; Frisch I; Jakob K; Kleemann J; Riegel D; Bönisch U; Lukassen S; Eccles RL; Schmidl C; Stemmler MP; Brabletz T; Brabletz S
    EMBO J; 2020 Sep; 39(17):e103209. PubMed ID: 32692442
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibition of long non-coding RNA MALAT1 elevates microRNA-429 to suppress the progression of hypopharyngeal squamous cell carcinoma by reducing ZEB1.
    Liu X; Zhao W; Wang X
    Life Sci; 2020 Dec; 262():118480. PubMed ID: 32980391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis.
    He L; Gao L; Shay C; Lang L; Lv F; Teng Y
    J Exp Clin Cancer Res; 2019 Feb; 38(1):84. PubMed ID: 30777099
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ZEB1 is neither sufficient nor required for epithelial-mesenchymal transition in LS174T colorectal cancer cells.
    Jägle S; Dertmann A; Schrempp M; Hecht A
    Biochem Biophys Res Commun; 2017 Jan; 482(4):1226-1232. PubMed ID: 27923654
    [TBL] [Abstract][Full Text] [Related]  

  • 58. ΔNp63α attenuates tumor aggressiveness by suppressing miR-205/ZEB1-mediated epithelial-mesenchymal transition in cervical squamous cell carcinoma.
    Zhao W; Wang H; Han X; Ma J; Zhou Y; Chen Z; Zhou H; Xu H; Sun Z; Kong B; Fang H
    Tumour Biol; 2016 Aug; 37(8):10621-32. PubMed ID: 26864590
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Schisandrin B inhibits TGF-β1-induced epithelial-mesenchymal transition in human A549 cells through epigenetic silencing of ZEB1.
    Zhuang W; Li Z; Dong X; Zhao N; Liu Y; Wang C; Chen J
    Exp Lung Res; 2019; 45(5-6):157-166. PubMed ID: 31268360
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.